Matthew Davids, MD on Phase II Study of Venetoclax: Standard of Care @DanaFarber

Matthew Davids, MD on Phase II Study of Venetoclax: Standard of Care @DanaFarber

User Photo
Cancer-News

2 weeks
10 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Matthew S. Davids, MD of Dana Farber Cancer Institute @DanaFarber discusses a multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH for Richter’s syndrome.

Read here: https://meetinglibrary.asco.org/record/186876/abstract

Up Next Autoplay
User Photo